I agree with your analysis.
The transaction is disappointing IMO.
The worlwide distribution agreements in place have not yet provided much fruit. Definitely not what Dr Luke Reid was promoting at the IPO.
Microba is valuing the company at 30% less than the market was while carrying out this acquisition at 23 cents a share.
I think its a big mistake. They state that Invivo is cashflow neutral but no doubt in Microba's hands it will have added costs in pushing for growth and expanding the product range with Microba products. Also the current owners probably ran the company on a shoestring and now probably have wages that are more in line with market.
- Forums
- ASX - By Stock
- Ann: Investor Presentation
MAP
microba life sciences limited
Add to My Watchlist
0.00%
!
9.2¢

I agree with your analysis.The transaction is disappointing...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.38M |
Open | High | Low | Value | Volume |
9.3¢ | 9.3¢ | 9.2¢ | $4.641K | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 11774 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 114482 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11774 | 0.092 |
4 | 60967 | 0.091 |
7 | 405677 | 0.090 |
2 | 192844 | 0.089 |
2 | 12552 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 114482 | 1 |
0.099 | 195500 | 2 |
0.105 | 103000 | 1 |
0.110 | 1714 | 1 |
0.120 | 195000 | 1 |
Last trade - 15.57pm 30/07/2025 (20 minute delay) ? |
Featured News
MAP (ASX) Chart |